Preliminary study on the effects of enrofloxacin, flunixin meglumine and pegbovigrastim on Mycoplasma bovis pneumonia

BACKGROUND: Mycoplasma bovis is a causative agent of disease in cattle causing many clinical conditions. Currently there are no commercial M. bovis vaccines in Europe and treatment is difficult with decreased antimicrobial susceptibility of M. bovis field isolates. Using an M. bovis calf infection m...

Descripción completa

Detalles Bibliográficos
Autores principales: Dudek, Katarzyna, Bednarek, Dariusz, Ayling, Roger D., Kycko, Anna, Reichert, Michał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815429/
https://www.ncbi.nlm.nih.gov/pubmed/31655595
http://dx.doi.org/10.1186/s12917-019-2122-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815429/
https://www.ncbi.nlm.nih.gov/pubmed/31655595
http://dx.doi.org/10.1186/s12917-019-2122-3

Ejemplares similares